Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: The clinical trial titled ...

To date, more than 50% of the patients in the study have been enrolled in seven European countries. The study is testing AC102 as a novel, more effective treatment for sudden hearing loss with fewer ...

June marks Alzheimer’s & Brain Awareness Month — a time to shine a light on the importance of how we can best protect our brain health and prevent cognitive decline While many people focus on diet, ...

Studies have found that individuals with untreated hearing loss experience cognitive decline at a faster rate than those with normal hearing. While hearing loss doesn't directly cause dementia, it ...

HEPPENHEIM, Germany & BERLIN--(BUSINESS WIRE)--There is currently no drug approved worldwide for the treatment of sudden hearing loss. However, preclinical and clinical phase-1-studies with the ...

In this week's episode, Rex talks with otolaryngologist Dr. Susan Emmett from UAMS about the dangers of hearing loss and the ...

A woman having trouble with hearing gestures for increased volume. [Getty Images] Hearing loss is one of the world’s most prevalent chronic conditions, affecting people of all ages. It interferes with ...

SALT LAKE CITY — A new study published in JAMA suggests that nearly one in three dementia cases could be connected to hearing loss — raising concerns about why it’s important to catch hearing problems ...

A new development with mouse embryonic stem cells could pave the way for future research into human hearing — and even a cure for some types of hearing loss. A study published in the May 14 issue of ...

Hearing problems were a common side effect reported in studies of Tepezza (teprotumumab-trbw). These include hearing loss, which may lead to deafness. Share on Pinterest aquaArts studio/Getty Images ...

Intra-arterial Paraplatin did not cause hearing loss in children with retinoblastoma, as shown by DPOAE testing. DPOAE testing is a noninvasive, reliable method for assessing cochlear function and ...

BERLIN--(BUSINESS WIRE)--Berlin-based start-up AudioCure Pharma has enrolled more than 50% of the planned patients in its ongoing Phase 2 clinical trial. The aim of the study is to test the efficacy ...